Please wait while the formulary information is being retrieved.
ZEPHREX-D (PSEUDOEPHEDRINE HCL)
- Nasal congestion
30 mg tablet
- 2 tablets (60 mg) by oral route every 4-6 hours as needed not toexceed 8 tablets per 24Hrs
30 mg tablet
- 2 tablets (60 mg) by oral route every 4-6 hours as needed not toexceed 8 tablets per 24Hrs
Nasal congestion
- 2 tablets (60 mg) by oral route every 6 hours as needed
- 2 tablets (60 mg) by oral route every 4 hours as needed not to exceed 8 tablets per 24Hrs
- 2 tablets (60 mg) by oral route every 4-6 hours as needed not toexceed 8 tablets per 24Hrs
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- linezolid
- methylergonovine
- Migergot
- Migranal
- Parlodel
- rasagiline
- selegiline HCl
- Zelapar
- Zyvox
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Angle-closure glaucoma
- Severe coronary artery disease
- Severe uncontrolled hypertension
- Urinary retention
Contraindicated
- Benign prostatic hyperplasia
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
Severe
Moderate
- None
ZEPHREX-D (PSEUDOEPHEDRINE HCL)
- Nasal congestion
- None
- Headache disorder
- Insomnia
More Frequent
Severe
Less Severe
- None
- Agitation
- Anorexia
- Dizziness
- Drowsy
- Dysuria
- General weakness
- Nausea
- Nervousness
- Pallor
- Tachycardia
- Tremor
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute generalized exanthematous pustulosis
- Dyspnea
- Hallucinations
- Hypertension
- Ischemic colitis
- Seizure disorder
- Vomiting
Less Severe
- Abdominal pain with cramps
- Cardiac arrhythmia
- Dyspepsia
- Excitement
- Hyperhidrosis
- Palpitations
- Symptoms of anxiety
Contraindicated
Pseudoephedrine (Immed. Release)
High risk of adverse CNS effects. Not recommended for use age < 6 years.
- 1 Day – 6 Years
- 1 High risk of adverse CNS effects. Not recommended for use age < 6 years.
Severe Precaution
None
Management or Monitoring Precaution
None
Pseudoephedrine
- Severity Level:
C
- Additional Notes: Fda c w/combo prod; poss risk of gastroschisis/sia with 1st trimester exposure
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pseudoephedrine
May decrease milk supply, and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | May decrease milk supply, and cause irritability |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Pseudoephedrine
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Nasal congestion | |
| R09.81 | Nasal congestion |
| 0-9 | A-Z |
|---|---|
| R09.81 | Nasal congestion |
Formulary Reference Tool